CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

106 hedge funds and large institutions have $186M invested in Cymabay Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-12
Holders Change %
-10.17%
% of All Funds
1.79%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
20
Increased
30
Reduced
32
Closed
28
Calls
$801K
Puts
$345K
Net Calls
+$456K
Net Calls Change
+$107K

Top Buyers

1
LCM
1
Laurion Capital Management
New York
$4.65M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$7.64M
3
NCM
3
Nantahala Capital Management
Connecticut
$7.8M
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$4.43M
5
Millennium Management
5
Millennium Management
New York
$8.9M

Top Sellers

1
BlackRock
1
BlackRock
New York
$5.76M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$10K
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.48M
4
State Street
4
State Street
Massachusetts
$1.07M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$2.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
PNC Financial Services Group
126
PNC Financial Services Group
Pennsylvania
– -$2K -442 Closed
2 3 4 5
6